Mesenchymal stem cell therapy shows promise for treating MS, but more research is needed on long-term safety and efficacy, a review found.

Tyruko, the first biosimilar of Tysabri, is now available in the U.S., providing a lower-cost treatment option for adults ...

Please provide your email address to receive an email when new articles are posted on . Top-line results of a phase 2 clinical trial for an adipose-derived autologous mesenchymal stem cell therapy to ...

Today, a new approach is giving patients and their physicians reason to hope. Moffitt Cancer Center has expanded its ...

For people living with multiple sclerosis (MS), the search for effective treatment options can feel like a never-ending journey. While disease-modifying therapies (DMTs) have improved outcomes for ...

There’s a spring in former Carson High School teacher Phil Brady’s step now that he doesn’t have to rely on his wheelchair ...

A study led by Cambridge researchers has shed light on how neural stem cell grafts could help restore myelin in the central nervous system. The findings suggest that neural stem cell-based therapies ...

Union City Commissioner Douglas Bine filed the suit in November of 2024 after losing his seat in a close election. New report reveals families in southern Ohio living on land at risk of causing cancer ...

Listen to Post Therapies for Multiple Sclerosis: Exploring Treatments for MS Multiple sclerosis (MS) is a ...

BUFFALO, N.Y. — When the myelin sheath that surrounds nerve fibers in the brain and spinal cord becomes damaged, a number of debilitating conditions can result that limit mobility, inhibit ...